Primary Adenocarcinoma of the Bulbomembranous Urethra in a 33-Year-Old Male Patient

Primary Urethral Carcinoma (PUC) is considered as a rare tumour, accounts for less than 1% of all malignancies and an incidence rate of four cases per million patients. Incidence increases with the patient’s age and most commonly present in seventh decades. Urothelial carcinoma is the most common...

Full description

Bibliographic Details
Main Authors: Rupesh Gupta, Sweta Gupta, Supriya Basu, Priyatosh Dey, Imran Ahmad Khan
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2017-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/10581/28918_CE[Ra]_F(Sh)PF1_(VT_PY)_PFA(VJ_SS).pdf
Description
Summary:Primary Urethral Carcinoma (PUC) is considered as a rare tumour, accounts for less than 1% of all malignancies and an incidence rate of four cases per million patients. Incidence increases with the patient’s age and most commonly present in seventh decades. Urothelial carcinoma is the most common type (76%) of the PUC, adenocarcinoma accounts for less than 5% of the PUC. No definitive protocol for tumour management for urethral adenocarcinoma has been described in the literature due to lack of prospective study and scarcity of the cases. Treatment usually depends on the site and stage of the tumour. We hereby report a case of 33-year-old male patient with urethral adenocarcinoma of bulbomembranous urethra spread to the prostatic urethra and left side inguinal lymph node. He was treated through multimodal therapy with surgery plus adjuvant chemotherapy.
ISSN:2249-782X
0973-709X